Deutsche Bank AG set a €90.00 ($105.88) price target on MorphoSys AG (ETR:MOR) in a report issued on Monday. The firm currently has a buy rating on the stock.

Other research analysts have also recently issued research reports about the company. Commerzbank Ag set a €76.00 ($89.41) price objective on MorphoSys AG and gave the stock a buy rating in a research note on Friday, July 14th. Berenberg Bank set a €68.00 ($80.00) price objective on MorphoSys AG and gave the stock a buy rating in a research note on Friday, July 14th. Independent Research GmbH set a €77.00 ($90.59) price objective on MorphoSys AG and gave the stock a buy rating in a research note on Monday, July 17th. Finally, Oddo Bhf set a €76.00 ($89.41) price objective on MorphoSys AG and gave the stock a buy rating in a research note on Thursday, September 7th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of Buy and a consensus target price of €79.00 ($92.94).

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/deutsche-bank-ag-analysts-give-morphosys-ag-mor-a-90-00-price-target/1674527.html.

About MorphoSys AG

MorphoSys AG, together with its subsidiaries, engages in the research, development, and optimization of therapeutic antibody drug candidates in partnerships with pharmaceutical and biotechnology companies. The company, together with its pharmaceutical partners, develops a therapeutic pipeline of approximately 100 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, Alzheimer's disease, infectious diseases, cardiovascular dysfunction, and inflammation.

Analyst Recommendations for MorphoSys AG (ETR:MOR)

Receive News & Ratings for MorphoSys AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MorphoSys AG and related companies with Analyst Ratings Network's FREE daily email newsletter.